Oncology and medical device developer RITA Medical Systems of Fremont, CA, has begun sales of its LC Bead embolization product in the U.S.
The new product is a minimally invasive embolization treatment for hypervascular tumors that blocks the blood flow feeding a tumor, causing it to shrink in size over time. The technique is commonly used to treat hepatocellular carcinoma and neuroendocrine tumors, the company said.
RITA has an exclusive three-year supply and distribution agreement with the manufacturer of LC Bead, U.K.-based Biocompatibles International, to market the product in the U.S. and Canada.
By AuntMinnie.com staff writers
July 11, 2006
Related Reading
RITA notches Q1 revenue gain, May 10, 2006
RITA launches OmniPICC PI, February 28, 2006
RITA shows sales gains, increased losses, February 24, 2006
RITA boosts sales, trims losses, November 2, 2005
RITA names Angel as CFO, October 18, 2005
Copyright © 2006 AuntMinnie.com
